1. Home
  2. VRNA vs DOX Comparison

VRNA vs DOX Comparison

Compare VRNA & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • DOX
  • Stock Information
  • Founded
  • VRNA 2005
  • DOX 1982
  • Country
  • VRNA United Kingdom
  • DOX United States
  • Employees
  • VRNA N/A
  • DOX N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • DOX EDP Services
  • Sector
  • VRNA Health Care
  • DOX Technology
  • Exchange
  • VRNA Nasdaq
  • DOX Nasdaq
  • Market Cap
  • VRNA 8.3B
  • DOX 9.5B
  • IPO Year
  • VRNA 2017
  • DOX 1998
  • Fundamental
  • Price
  • VRNA $106.27
  • DOX $83.98
  • Analyst Decision
  • VRNA Buy
  • DOX Strong Buy
  • Analyst Count
  • VRNA 11
  • DOX 4
  • Target Price
  • VRNA $114.10
  • DOX $105.33
  • AVG Volume (30 Days)
  • VRNA 1.3M
  • DOX 814.7K
  • Earning Date
  • VRNA 11-03-2025
  • DOX 11-11-2025
  • Dividend Yield
  • VRNA N/A
  • DOX 2.51%
  • EPS Growth
  • VRNA N/A
  • DOX 13.12
  • EPS
  • VRNA N/A
  • DOX 4.90
  • Revenue
  • VRNA $221,673,000.00
  • DOX $4,646,577,000.00
  • Revenue This Year
  • VRNA $896.59
  • DOX N/A
  • Revenue Next Year
  • VRNA $77.56
  • DOX $4.09
  • P/E Ratio
  • VRNA N/A
  • DOX $17.17
  • Revenue Growth
  • VRNA N/A
  • DOX N/A
  • 52 Week Low
  • VRNA $27.54
  • DOX $78.61
  • 52 Week High
  • VRNA $106.45
  • DOX $95.41
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 68.40
  • DOX 41.34
  • Support Level
  • VRNA $106.15
  • DOX $83.56
  • Resistance Level
  • VRNA $106.42
  • DOX $86.14
  • Average True Range (ATR)
  • VRNA 0.19
  • DOX 1.49
  • MACD
  • VRNA -0.17
  • DOX -0.07
  • Stochastic Oscillator
  • VRNA 76.32
  • DOX 21.39

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About DOX Amdocs Limited

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Share on Social Networks: